marijuana stocks news

Enertopia Corp. (ENRT)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Nov 30, 2014 Aug 31, 2014 May 31, 2014 Feb 28, 2014
Total Revenue –   –   –   –  
Cost of Revenue – – – –
Gross Profit –   –   –   –  
Operating Expenses
Research Development – – – –
Selling General and Administrative 534 640 1,263 227
Non Recurring 24 33 36 10
Others – – – –
Total Operating Expenses – – – –
Operating Income or Loss (558) (674) (1,299) (237)
Income from Continuing Operations
Total Other Income/Expenses Net (404) (2,655) 450 (77)
Earnings Before Interest And Taxes (962) (3,329) (849) (314)
Interest Expense – – – –
Income Before Tax (962) (3,329) (849) (314)
Income Tax Expense – – – –
Minority Interest – – – –
Net Income From Continuing Ops (962) (3,196) (973) (323)
Non-recurring Events
Discontinued Operations – – – –
Extraordinary Items – – – –
Effect Of Accounting Changes – – – –
Other Items – – – –
Net Income (962) (3,196) (973) (323)
Preferred Stock And Other Adjustments – – – –
Net Income Applicable To Common Shares (962) (3,196) (973) (323)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Tetra Bio-Pharma Inc. (TBPMF) Targeted Pharmaceutical & the George Mason University Partner on ARDS-003 to Prevent & Treat COVID-19

Tetra Bio-Pharma, Targeted Pharmaceutical & the George Mason University Partner on ARDS-003…

TerrAscend Corp. (TRSSF) Launches First-Ever Concentrates in New Jersey

TerrAscend Launches First-Ever Concentrates in New Jersey TerrAscend Corp. (“TerrAscend” or the…

$OGRMF Says “Hello Mr. President”

OrganiGram Announces Appointment of President MONCTON, NEW BRUNSWICK–(Marketwired – Oct 21, 2014)…

MariMed, Inc. (MRMD) Appoints Jon Levine as Interim Chief Executive Officer

MariMed Appoints Jon Levine as Interim Chief Executive Officer MariMed, Inc. (“MariMed”…